1. Fang, Leiming, Liu, Qi, Cui, Hongtu, Zheng, Yunji, Wu, Chengjun. 2022. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers. In Genes, 13, . doi:10.3390/genes13040654. https://pubmed.ncbi.nlm.nih.gov/35456460/
2. Li, Bin, Zhu, Hai-Bo, Song, Gui-Dong, Zhang, Ya-Zhuo, Zhao, Peng. 2019. Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition. In Oncology letters, 18, 4651-4658. doi:10.3892/ol.2019.10847. https://pubmed.ncbi.nlm.nih.gov/31611974/
3. Lu, Xiao-Qing, Zhang, Jia-Qian, Zhang, Sheng-Xiao, Gao, Chong, Zhang, Huan-Hu. 2021. Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis. In BMC cancer, 21, 697. doi:10.1186/s12885-021-08358-7. https://pubmed.ncbi.nlm.nih.gov/34126961/
4. Xiao, Xie, Rui, Bi, Rui, Hu, Ju, Mei, Hongtao, Liu. 2021. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1. In Environmental toxicology, 37, 504-513. doi:10.1002/tox.23416. https://pubmed.ncbi.nlm.nih.gov/34837450/